Published in J Bacteriol on March 01, 1966
Linkage map of Salmonella typhimurium, edition IV. Bacteriol Rev (1972) 6.89
Extrachromosomal elements as possible agents of adaptation and development. Bacteriol Rev (1976) 5.62
Revised linkage map of Salmonella typhimurium. Bacteriol Rev (1967) 5.22
Current linkage map of Salmonella typhimurium. Bacteriol Rev (1970) 4.60
Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens. Infect Immun (1972) 3.33
Genetic Transfer of Shigella flexneri Antigens to Escherichia coli K-12. Infect Immun (1970) 2.71
Genetic analysis of the ViA-his chromosomal region in Salmonella. J Bacteriol (1966) 2.17
Genetic determination of enzymes synthesizing O-specific sugars of Salmonella lipopolysaccharides. J Bacteriol (1966) 1.58
Molecular cloning, characterization, and nucleotide sequence of the rfc gene, which encodes an O-antigen polymerase of Salmonella typhimurium. J Bacteriol (1991) 1.46
P22-mediated transduction analysis of the rough A (rfa) region of the chromosome of Salmonella typhimurium. J Bacteriol (1972) 1.37
Presence of rfe genes in Escherichia coli: their participation in biosynthesis of O antigen and enterobacterial common antigen. J Bacteriol (1976) 1.32
Enterobacterial common antigen in rfb deletion mutants of Salmonella typhimurium. J Bacteriol (1976) 1.22
Escherichia coli ras locus: its involvement in radiation repair. J Bacteriol (1969) 1.13
Effect of enterobacterial common antigen on mouse virulence of Salmonella typhimurium. Infect Immun (1976) 1.11
Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1. Infect Immun (1984) 1.03
Somatic antigen 2 inheritance in Salmonella groups B and D. J Bacteriol (1967) 0.87
Bacteriophage-mediated Glucosylation Can Modify Lipopolysaccharide O-Antigens Synthesized by an ATP-binding Cassette (ABC) Transporter-dependent Assembly Mechanism. J Biol Chem (2015) 0.82
T2 lipopolysaccharide antigen of Salmonella: genetic determination of T2 and properties of the T2, T2,S, and T2,SR Forms. Infect Immun (1976) 0.80
Hybrids of enteric bacteria.I. S. Typhimurium--S. montevideo hybrids for the histidine loci. Genetics (1968) 0.75
Genetic exchange in Salmonella. J Bacteriol (1952) 23.68
THE LINKAGE MAP OF SALMONELLA TYPHIMURIUM. Genetics (1965) 8.62
Mutation of bacteria at high levels of survival by ethyl methane sulphonate. Nature (1959) 5.83
Studies on the chemical basis of the phage conversion of O-antigens in the E-group Salmonellae. Biochemistry (1962) 4.23
ROUGH MUTANTS OF SALMONELLA TYPHIMURIUM. I. GENETICS. Nature (1964) 3.98
LIPOPOLYSACCHARIDE OF THE GRAM-NEGATIVE CELL WALL. Science (1964) 3.85
[On the immunochemistry of O antigens of Enterobacteriaceae. I. Analysis of the sugar component of Salmonella O antigens]. Zentralbl Bakteriol (1960) 3.65
SEMIROUGH STRAINS OF SALMONELLA. Proc Natl Acad Sci U S A (1965) 3.26
GENETIC MAPPING OF VI AND SOMATIC ANTIGENIC DETERMINANTS IN SALMONELLA. J Bacteriol (1965) 2.90
ROUGH MUTANTS OF SALMONELLA TYPHIMURIUM. II. SEROLOGICAL AND CHEMICAL INVESTIGATIONS. Nature (1964) 2.88
Colicinogeny and recombination. Br Med Bull (1962) 2.85
Evidence for an intermediate stage in the biosynthesis of the Salmonella O-antigen. Proc Natl Acad Sci U S A (1965) 2.81
ROUGH MUTANTS OF SALMONELLA TYPHIMURIUM. III. ENZYMATIC SYNTHESIS OF NUCLEOTIDE-SUGAR COMPOUNDS. Nature (1964) 2.36
HFR males in Salmonella abony. Genetics (1963) 2.34
[Immunochemical study on Salmonella. VIII. Role of O acetyl groupings in the specificity of the O:5 factor]. Ann Inst Pasteur (Paris) (1961) 2.04
Biosynthesis of bacterial lipopolysaccharide. V. Lipid-linked intermediates in the biosynthesis of the O-antigen groups of Salmonella typhimurium. Proc Natl Acad Sci U S A (1965) 2.00
Inheritance of the O antigens of Salmonella groups B and D. J Gen Microbiol (1965) 1.79
BIOSYNTHESIS OF CELL WALL POLYSACCHARIDE IN MUTANT STRAINS OF SALMONELLA. IV. SYNTHESIS OF S-SPECIFIC SIDE-CHAIN. Biochem Biophys Res Commun (1965) 1.72
[Immunochemical study of Salmonella. V. Role of various sugars, especially 3, 6-bis-desoxyhexoses, in the specificity of Kauffmann-White O antigens]. Ann Inst Pasteur (Paris) (1959) 1.47
[On the immunochemistry of the O-antigen of Enterobacteriaceae. VI. Comparison of the sugar components of polysaccharides from S and R forms of Salmonella]. Zentralbl Bakteriol (1961) 1.43
[ON THE IMMUNOCHEMISTRY OF SOMATIC ANTIGENS OF ENTEROBACTERIACEAE. X. R-SPECIFIC STRUCTURES IN SALMONELLA O ANTIGENS]. Biochem Z (1964) 1.16
Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56
Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Eur J Biochem (1980) 8.05
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01
F + , Hfr, and F' strains of Salmonella typhimurium and Salmonella abony. Bacteriol Rev (1972) 3.73
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet (1982) 3.39
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med (1984) 3.37
Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infect Immun (1979) 2.53
Effect of polymyxin on the ultrastructure of the outer membrane of wild-type and polymyxin-resistant strain of Salmonella. J Bacteriol (1976) 2.43
Enterobacterial common antigen. Bacteriol Rev (1976) 2.41
The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science (1983) 2.22
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis (1996) 2.15
Bacteriophage-resistant mutants of Salmonella typhimurium deficient in two major outer membrane proteins. J Bacteriol (1976) 2.02
Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet (1975) 1.97
A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91
Risk factors for pneumonia in the elderly. Am J Med (1994) 1.89
The role of IFN-gamma in murine Salmonella typhimurium infection. Microb Pathog (1990) 1.84
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Inheritance of the O antigens of Salmonella groups B and D. J Gen Microbiol (1965) 1.79
New Salmonella typhimurium mutants with altered outer membrane permeability. J Bacteriol (1984) 1.76
Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid. J Biol Chem (1985) 1.71
A novel virulence-associated cell surface structure composed of 47-kd protein subunits in Yersinia enterocolitica. EMBO J (1985) 1.68
Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin. Mol Microbiol (1993) 1.66
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics (1984) 1.65
Genetic aspects of biosynthesis and structure of Salmonella somatic polysaccharide. Ann N Y Acad Sci (1966) 1.64
An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. J Immunol (1984) 1.62
Mutants defective in the 33K outer membrane protein of Salmonella typhimurium. J Bacteriol (1979) 1.60
The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis (1981) 1.59
Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J (1998) 1.59
Genetic determination of enzymes synthesizing O-specific sugars of Salmonella lipopolysaccharides. J Bacteriol (1966) 1.58
Role of O-antigen (lipopolysaccharide) factors in the virulence of Salmonella. J Infect Dis (1973) 1.57
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53
Participation of lipopolysaccharide genes in the determination of the enterobacterial common antigen: analysis of R mutants of Salmonella minnesota. J Bacteriol (1974) 1.52
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52
Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med (1997) 1.50
Protein K: a new major outer membrane protein found in encapsulated Escherichia coli. J Bacteriol (1979) 1.47
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis (2001) 1.47
Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol (1982) 1.45
Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus. Infect Immun (1984) 1.41
Fimbrial phase variation and systemic E. coli infection studied in the mouse peritonitis model. Microb Pathog (1986) 1.40
Immunization with major outer membrane protein (porin) preparations in experimental murine salmonellosis: effect of lipopolysaccharide. Infect Immun (1981) 1.40
Triggering infections in reactive arthritis. Ann Rheum Dis (1985) 1.36
Antigenic properties of Chlamydia trachomatis lipopolysaccharide. Infect Immun (1985) 1.34
Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun (1983) 1.34
Genetic determination of bacterial virulence, with special reference to Salmonella. Curr Top Microbiol Immunol (1986) 1.34
Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis. Infect Immun (1975) 1.32
Presence of rfe genes in Escherichia coli: their participation in biosynthesis of O antigen and enterobacterial common antigen. J Bacteriol (1976) 1.32
Participation of lipopolysaccharide genes in the determination of the entobacterial common antigen: analysis in Salmonella groups B and C1. J Bacteriol (1974) 1.32
Pneumococcal vaccine and otitis media. Lancet (1980) 1.31
rfaP mutants of Salmonella typhimurium. Eur J Biochem (1989) 1.31
Bacteriophage attachment to the somatic antigen of salmonella: effect of o-specific structures in leaky R mutants and s, t1 hybrids. Infect Immun (1970) 1.28
Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis (1981) 1.27
Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study. Arch Intern Med (1999) 1.26
The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J Infect (1987) 1.24
Structural investigations on the core polysaccharide of Escherichia coli 0100. Eur J Biochem (1971) 1.24
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22
Enterobacterial common antigen in rfb deletion mutants of Salmonella typhimurium. J Bacteriol (1976) 1.22
Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis (1986) 1.22
Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet (1982) 1.21
Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J (1989) 1.20
Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr Infect Dis J (1989) 1.20
The smooth lipopolysaccharide character of 1,4,(5),12 and 1,9,12 transductants formed as hybrids between groups B and D of salmonella. Eur J Biochem (1971) 1.19
Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis (1976) 1.19
First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis (1986) 1.18
Glucosylation of lipopolysaccharide in Salmonella: biosynthesis of O antigen factor 12 2 . I. Over-all reaction. J Biol Chem (1971) 1.14
Biosynthesis of uridine diphosphate N-acetylmannosaminuronic acid in rff mutants of Salmonella tryphimurium. J Bacteriol (1978) 1.14
How genes determine the structure of the Salmonella lipopolysaccharide. J Gen Microbiol (1969) 1.13
Finnish approach to the treatment of acute otitis media. Report of the Finnish Consensus Conference. Ann Otol Rhinol Laryngol Suppl (1987) 1.13
Serological evidence for the role of bacterial infections in the pathogenesis of thyroid diseases. Acta Med Scand (1986) 1.12
Effect of enterobacterial common antigen on mouse virulence of Salmonella typhimurium. Infect Immun (1976) 1.11
Active immunity is seen as a reduction in the cell response to oral live vaccine. Vaccine (1991) 1.10
Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun (1998) 1.09
The virulence plasmid does not contribute to growth of Salmonella in cultured murine macrophages. Microb Pathog (1992) 1.09
Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J (1993) 1.08
Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis (1996) 1.07
Biosynthesis of O-antigenic polysaccharides in Salmonella. Ann N Y Acad Sci (1966) 1.07
Bacterial induction of human activated lymphocyte killing and its inhibition by lipopolysaccharide (LPS). J Immunol (1986) 1.07
Radioimmunoassay of capsular polysaccharide antigens of groups A and C meningococci and Haemophilus influenzae type b in cerebrospinal fluid. J Clin Pathol (1977) 1.07
Serological evidence for the role of Bacteroides fragilis and enterobacteriaceae in the pathogenesis of acute pelvic inflammatory disease. Lancet (1981) 1.06
Different profiles of the human immune response to primary and secondary immunization with an oral Salmonella typhi Ty21a vaccine. Vaccine (1991) 1.06
Haemophilus influenzae type b strains of outer membrane subtypes 1 and 1c cause different types of invasive disease. Lancet (1987) 1.05
An F' episome of Salmonella abony. Acta Pathol Microbiol Scand (1966) 1.05
Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media. Pediatr Infect Dis J (2001) 1.04
Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide. J Pediatr (1978) 1.04
The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci. Vaccine (1999) 1.04
Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology (1999) 1.03
Invasive Escherichia coli infections in children: bacterial characteristics in different age groups and clinical entities. Pediatr Infect Dis J (1993) 1.03
Biosynthesis of enterobacterial common antigen requires dTDPglucose pyrophosphorylase determined by a Salmonella typhimurium rfb gene and a Salmonella montevideo rfe gene. J Bacteriol (1986) 1.02
Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. Vaccine (1999) 1.02
Role of gamma interferon in late stages of murine salmonellosis. Infect Immun (1993) 1.02